QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 silo-pharma-announces-initial-purchase-of-bitcoin

SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or "the Company), a dive...

 silo-pharma-invests-in-desci-innovation-with-purchase-of-researchhubs-native-token-co-founded-by-coinbase-ceo-brian-armstrong

Company invests in DeSci blockchain innovation and purchases native coin of ResearchHub, a decentralized science platform co-fo...

 silo-pharma-secures-australian-patent-for-ptsd-treatment-spc-15-through-columbia-university-partnership

Silo Pharma, Inc.

 silo-pharma-announces-peer-reviewed-publication-of-spc-14-preclinical-data-for-alzheimers-disease-in-alzheimers-research--therapy-ceo-weisblum-cites-potential-for-targeted-dementia-therapies

Manuscript featured in leading open-access scientific journal Alzheimer's Research & TherapySARASOTA, FL, Aug. 21, 2025...

 silo-pharma-completes-dosing-in-fda-requested-7-day-safety-and-toxicology-large-animal-study-of-spc-15

Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focu...

Core News & Articles

*Hoth Therapeutics and Silo Pharma Launch Joint Venture to Commercialize VA-Invented Obesity Drug Targeting $100B+ Global Marke...

 us-stocks-likely-to-open-on-a-mixed-note-after-sp-500-scales-6000-mark-whole-globe-is-in-a-bull-market

U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION